Brief: Elusys Therapeutics Finalizes HHS Contract To Deliver Anthim

Scorpius Holdings

31/01/2022 12:41

Jan 31 (Reuters) - Heat Biologics Inc  HTBX.O :
    * ELUSYS THERAPEUTICS FINALIZES HHS CONTRACT TO DELIVER
ANTHIM®,
ITS TREATMENT FOR INHALATION ANTHRAX, TO U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
    * ELUSYS THERAPEUTICS- COMPLETED FIRST PHASE OF CONTRACT FOR
$50
MILLION; HHS OPTIONS TO PROCURE UP TO $31 MILLION OF ANTHIM BY
FIRST HALF OF 2023
    * ELUSYS THERAPEUTICS- CONTRACT 75A50121C00073 IS FUNDED BY
HHS
ASPR

Source text for Eikon:  ID:nGNX8D3jRp 
Further company coverage:  HTBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))